Composition for Preventing or Treating Benign Prostatic Hyperplasia Comprising High Maysin Corn Silk Extract
The present invention relates to a novel use of maysin, which is for preventing or treating benign prostatic hyperplasia. A composition containing maysin or a corn silk extract as an active component inhibits the expression of 5α reductase 2 mRNA in prostate to reduce a concentration of 5α-R2, there...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
14.03.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a novel use of maysin, which is for preventing or treating benign prostatic hyperplasia. A composition containing maysin or a corn silk extract as an active component inhibits the expression of 5α reductase 2 mRNA in prostate to reduce a concentration of 5α-R2, thereby inhibiting a conversion of testosterone to DHT to inhibit benign prostatic hyperplasia induced by testosterone. Therefore, the composition can be usefully used for preventing or treating benign prostatic hyperplasia.
본 발명은 메이신의 새로운 용도인 전립선 비대증의 예방 또는 치료용도에 관한 것으로, 메이신 또는 옥수수수염 추출물을 유효성분으로 함유하는 조성물은 전립선에서 5α 리덕타제 2(5α reductase 2) mRNA 발현을 억제하여 5α-R2 농도를 감소시켜 테스토스테론이 DHT로 전환되는 것을 억제함으로써 테스토스테론으로 유발된 전립선비대를 억제시킬 수 있어 전립선 비대증의 예방 또는 치료에 유용하게 사용할 수 있다. |
---|---|
Bibliography: | Application Number: KR20170132332 |